Zhang C#, Min YQ#, Xue H, Zhang H, Liu K, Tian Y, Yang Z, Zhao Z, Yang H, Shan C, Sun X, Ning YJ. 2025. Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target. Nat Commun 16:6326.
Min YQ#, Xiong W#, Shen W#, Liu X#, Qi Q#, Zhang Y, Fan R, Fu F, Xue H, Yang H, Sun X, Ning Y, Tian T, Zhou X. 2024. Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera. Sci Adv 10:eadl4393.
Min YQ, Huang M, Feng K, Jia Y, Sun X, Ning YJ. 2023. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications. Mol Cell Proteomics doi:10.1016/j.mcpro.2023.100579:100579.
Dai S#, Min YQ#, Li Q, Feng K, Jiang Z, Wang Z, Zhang C, Ren F, Fang Y, Zhang J, Zhu Q, Wang M, Wang H, Deng F, Ning YJ. 2023. Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins. Nat Commun 14:7365.
Hu J#, Min YQ#, Sun X. 2022. Cis-regulatory decoy disrupts autorepression: a potential escape-resistant anti-viral therapy. Signal Transduct Target Ther 7:338.
Feng K#, Min YQ#, Sun X, Deng F, Li P, Wang H, Ning YJ. 2021. Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling. J Mol Cell Biol doi:10.1093/jmcb/mjab068.
Min YQ#, Huang M#, Sun X, Deng F, Wang H, Ning YJ. 2021. Immune evasion of SARS-CoV-2 from interferon antiviral system. Comput Struct Biotechnol J 19:4217-4225.
Min YQ, Shi C, Yao T, Feng K, Mo Q, Deng F, Wang H, Ning YJ. 2020. The Nonstructural Protein of Guertu Virus Disrupts Host Defenses by Blocking Antiviral Interferon Induction and Action. ACS Infect Dis 6:857-870.
Min YQ, Ning YJ, Wang H, Deng F. 2020. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. J Biol Chem 295:9691-9711.
Wang SR#, Min YQ#, Wang JQ, Liu CX, Fu BS, Wu F, Wu LY, Qiao ZX, Song YY, Xu GH, Wu ZG, Huang G, Peng NF, Huang R, Mao WX, Peng S, Chen YQ, Zhu Y, Tian T, Zhang XL, Zhou X. 2016. A highly conserved G-rich consensus sequence in hepatitis C virus core gene represents a new anti-hepatitis C target. Sci Adv 2.